Liquid Biopsy in Non-Small Cell Lung Cancer: Highlights and Challenges
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Liquid Biopsy in Non-Small Cell Lung Cancer: Highlights and Challenges
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 1, Pages 17
Publisher
MDPI AG
Online
2019-12-23
DOI
10.3390/cancers12010017
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Exosome Analysis in Tumor-Draining Pulmonary Vein Identifies NSCLC Patients with Higher Risk of Relapse after Curative Surgery
- (2019) Alfons Navarro et al. Cancers
- Assessment of Blood Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Patients With Non–Small Cell Lung Cancer With Use of a Next-Generation Sequencing Cancer Gene Panel
- (2019) Zhijie Wang et al. JAMA Oncology
- Isolation of circulating tumor cells and detection of EGFR mutations in patients with non‑small‑cell lung cancer
- (2019) Qi Zhang et al. Oncology Letters
- Clinical significance of monitoring EGFR mutation in plasma using multiplexed digital PCR in EGFR mutated patients treated with afatinib (West Japan Oncology Group 8114LTR study)
- (2019) Hiroaki Akamatsu et al. LUNG CANCER
- The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients
- (2019) M. G. Dal Bello et al. Journal of Translational Medicine
- Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non–small Cell Lung Cancer
- (2019) Natasha B. Leighl et al. CLINICAL CANCER RESEARCH
- Tumor‐derived exosomal lncRNA GAS5 as a biomarker for early‐stage non‐small‐cell lung cancer diagnosis
- (2019) Chuling Li et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Tag-based next generation sequencing: a feasible and reliable assay for EGFR T790M mutation detection in circulating tumor DNA of non small cell lung cancer patients
- (2019) Mariella Dono et al. MOLECULAR MEDICINE
- Detection of circulating exosomal miR-17-5p serves as a novel non-invasive diagnostic marker for non-small cell lung cancer patients
- (2019) Yi Zhang et al. PATHOLOGY RESEARCH AND PRACTICE
- EGFR and HER3 expression in circulating tumor cells and tumor tissue from non-small cell lung cancer patients
- (2019) Heather Scharpenseel et al. Scientific Reports
- Prognostic Relevance of Circulating Tumor Cells and Circulating Cell-Free DNA Association in Metastatic Non-Small Cell Lung Cancer Treated with Nivolumab
- (2019) Alama et al. Journal of Clinical Medicine
- Determination of PD-L1 Expression in Circulating Tumor Cells of NSCLC Patients and Correlation with Response to PD-1/PD-L1 Inhibitors
- (2019) Melanie Janning et al. Cancers
- Baseline serum levels of osteopontin predict clinical response to treatment with nivolumab in patients with non-small cell lung cancer
- (2019) Federico Carbone et al. CLINICAL & EXPERIMENTAL METASTASIS
- Systemic Therapy for Locally Advanced and Metastatic Non–Small Cell Lung Cancer
- (2019) Kathryn C. Arbour et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Prospective detection of mutations in cerebrospinal fluid, pleural effusion and ascites of advanced cancer patients to guide treatment decisions
- (2019) Sergio Villatoro et al. Molecular Oncology
- Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse
- (2019) Francesca Chemi et al. NATURE MEDICINE
- Exosomes in lung cancer diagnosis and treatment. From the translating research into future clinical practice
- (2018) Christos Masaoutis et al. BIOCHIMIE
- Clinical Utility of Cell-Free DNA for the Detection ofALKFusions and Genomic Mechanisms of ALK Inhibitor Resistance in Non–Small Cell Lung Cancer
- (2018) Caroline E. McCoach et al. CLINICAL CANCER RESEARCH
- PD-L1 expression in circulating tumor cells of advanced non-small cell lung cancer patients treated with nivolumab
- (2018) Nicolas Guibert et al. LUNG CANCER
- Correlation between progression-free survival, tumor burden, and circulating tumor DNA in the initial diagnosis of advanced-stage EGFR -mutated non-small cell lung cancer
- (2018) Yunkyoung Lee et al. Thoracic Cancer
- Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab
- (2018) David R. Gandara et al. NATURE MEDICINE
- A 5-MicroRNA Signature Identified from Serum MicroRNA Profiling Predicts Survival in Patients with Advanced Stage Non-Small Cell Lung Cancer
- (2018) Yajie Zhang et al. CARCINOGENESIS
- The role of circulating free DNA in the management of NSCLC
- (2018) Riziero Esposito Abate et al. Expert Review of Anticancer Therapy
- Identification of tumor-educated platelet biomarkers of non-small-cell lung cancer
- (2018) Meiling Sheng et al. OncoTargets and Therapy
- Impacts of Cancer on Platelet Production, Activation and Education and Mechanisms of Cancer-Associated Thrombosis
- (2018) Léa Plantureux et al. Cancers
- Roles of exosomes in the carcinogenesis and clinical therapy of non-small cell lung cancer
- (2018) Sile Liu et al. BIOMEDICINE & PHARMACOTHERAPY
- A combination of platelet features allows detection of early-stage cancer
- (2017) Siamack Sabrkhany et al. EUROPEAN JOURNAL OF CANCER
- Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy
- (2017) Simona Coco et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Quantitative Analysis of Circulating Cell-Free DNA for Correlation with Lung Cancer Survival: A Systematic Review and Meta-Analysis
- (2017) Sarah Cargnin et al. Journal of Thoracic Oncology
- Circulating Tumor Cells Predict Prognosis Following Tyrosine Kinase Inhibitor Treatment in EGFR-Mutant Non-Small Cell Lung Cancer Patients
- (2017) Baohong Yang et al. ONCOLOGY RESEARCH
- Quantification of circulating cell-free DNA to predict patient survival in non-small-cell lung cancer
- (2017) Myung Han Hyun et al. Oncotarget
- The clinical use of circulating microRNAs as non-invasive diagnostic biomarkers for lung cancers
- (2017) Yanlong Yang et al. Oncotarget
- Comparative analysis of circulating tumor DNA stability In K3EDTA, Streck, and CellSave blood collection tubes
- (2016) Qing Kang et al. CLINICAL BIOCHEMISTRY
- Extracellular vesicles as new players in angiogenesis
- (2016) Sharad Kholia et al. VASCULAR PHARMACOLOGY
- Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients
- (2016) Jacob J. Chabon et al. Nature Communications
- Use of capture-based next-generation sequencing to detect ALK fusion in plasma cell-free DNA of patients with non-small-cell lung cancer
- (2016) Shaohua Cui et al. Oncotarget
- Guide to detecting epidermal growth factor receptor (EGFR) mutations in ctDNA of patients with advanced non-small-cell lung cancer
- (2016) Nicola Normanno et al. Oncotarget
- Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab
- (2016) Chiara Nicolazzo et al. Scientific Reports
- Detection of T790M, the Acquired Resistance EGFR Mutation, by Tumor Biopsy versus Noninvasive Blood-Based Analyses
- (2015) T. K. Sundaresan et al. CLINICAL CANCER RESEARCH
- Early Detection of Lung Cancer in Serum by a Panel of MicroRNA Biomarkers
- (2015) Ping Wang et al. Clinical Lung Cancer
- Next-Generation Sequencing Workflow for NSCLC Critical Samples Using a Targeted Sequencing Approach by Ion Torrent PGM™ Platform
- (2015) Irene Vanni et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Exosomes in cancer: small particle, big player
- (2015) Xu Zhang et al. Journal of Hematology & Oncology
- miR-Test: A Blood Test for Lung Cancer Early Detection
- (2015) Francesca Montani et al. JNCI-Journal of the National Cancer Institute
- Challenges in circulating tumor cell detection by the CellSearch system
- (2015) Kiki C. Andree et al. Molecular Oncology
- Acquired EGFR C797S mutation mediates resistance to AZD9291 in non–small cell lung cancer harboring EGFR T790M
- (2015) Kenneth S Thress et al. NATURE MEDICINE
- miR-Test: A Blood Test for Lung Cancer Early Detection
- (2015) Francesca Montani et al. JNCI-Journal of the National Cancer Institute
- Circulating MicroRNAs as Non-Invasive Biomarkers for Early Detection of Non-Small-Cell Lung Cancer
- (2015) Magdalena B. Wozniak et al. PLoS One
- Double-stranded DNA in exosomes: a novel biomarker in cancer detection
- (2014) Basant Kumar Thakur et al. CELL RESEARCH
- Prognostic and predictive relevance of circulating tumor cells in patients with non-small-cell lung cancer
- (2014) Angela Alama et al. DRUG DISCOVERY TODAY
- Clinical Utility of a Plasma-Based miRNA Signature Classifier Within Computed Tomography Lung Cancer Screening: A Correlative MILD Trial Study
- (2014) Gabriella Sozzi et al. JOURNAL OF CLINICAL ONCOLOGY
- Liquid Biopsies: Genotyping Circulating Tumor DNA
- (2014) Luis A. Diaz et al. JOURNAL OF CLINICAL ONCOLOGY
- miRNA in Plasma Exosome is Stable under Different Storage Conditions
- (2014) Qinyu Ge et al. MOLECULES
- Clinical relevance of circulating cell-free microRNAs in cancer
- (2014) Heidi Schwarzenbach et al. Nature Reviews Clinical Oncology
- The correlation between cell-free DNA and tumour burden was estimated by PET/CT in patients with advanced NSCLC
- (2013) A D Nygaard et al. BRITISH JOURNAL OF CANCER
- Pathway-Based Serum microRNA Profiling and Survival in Patients with Advanced Stage Non-Small Cell Lung Cancer
- (2013) Y. Wang et al. CANCER RESEARCH
- Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
- (2013) Muhammed Murtaza et al. NATURE
- Application of a Highly Sensitive Detection System for Epidermal Growth Factor Receptor Mutations in Plasma DNA
- (2012) Tomomi Nakamura et al. Journal of Thoracic Oncology
- EGFR Array: Uses in the Detection of Plasma EGFR Mutations in Non–Small Cell Lung Cancer Patients
- (2012) Irene Yam et al. Journal of Thoracic Oncology
- Intercellular communication: diverse structures for exchange of genetic information
- (2012) Maria Mittelbrunn et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Extracellular miRNAs: the mystery of their origin and function
- (2012) Andrey Turchinovich et al. TRENDS IN BIOCHEMICAL SCIENCES
- Blood platelets contain tumor-derived RNA biomarkers
- (2011) R. J. A. Nilsson et al. BLOOD
- A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas
- (2011) F Farace et al. BRITISH JOURNAL OF CANCER
- Analysis of Circulating MicroRNA: Preanalytical and Analytical Challenges
- (2011) J. S. McDonald et al. CLINICAL CHEMISTRY
- Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer
- (2011) Niels H.H. Heegaard et al. INTERNATIONAL JOURNAL OF CANCER
- Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non–Small-Cell Lung Cancer
- (2011) Matthew G. Krebs et al. JOURNAL OF CLINICAL ONCOLOGY
- MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins
- (2011) Kasey C. Vickers et al. NATURE CELL BIOLOGY
- High Fragmentation Characterizes Tumour-Derived Circulating DNA
- (2011) Florent Mouliere et al. PLoS One
- Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma
- (2011) J. D. Arroyo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Serum MicroRNA Signatures Identified in a Genome-Wide Serum MicroRNA Expression Profiling Predict Survival of Non–Small-Cell Lung Cancer
- (2010) Zhibin Hu et al. JOURNAL OF CLINICAL ONCOLOGY
- Plasma microRNAs as potential biomarkers for non-small-cell lung cancer
- (2010) Jun Shen et al. LABORATORY INVESTIGATION
- Single-Molecule Detection of Epidermal Growth Factor Receptor Mutations in Plasma by Microfluidics Digital PCR in Non-Small Cell Lung Cancer Patients
- (2009) T. K.F. Yung et al. CLINICAL CANCER RESEARCH
- HER Family Receptor Abnormalities in Lung Cancer Brain Metastases and Corresponding Primary Tumors
- (2009) M. Sun et al. CLINICAL CANCER RESEARCH
- Noninvasive Detection of EGFR T790M in Gefitinib or Erlotinib Resistant Non-Small Cell Lung Cancer
- (2009) Y. Kuang et al. CLINICAL CANCER RESEARCH
- Exosomal MicroRNA: A Diagnostic Marker for Lung Cancer
- (2009) Guilherme Rabinowits et al. Clinical Lung Cancer
- Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR
- (2009) K. Al-Nedawi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases
- (2008) Xi Chen et al. CELL RESEARCH
- Circulating mutant DNA to assess tumor dynamics
- (2008) Frank Diehl et al. NATURE MEDICINE
- Detection of Mutations inEGFRin Circulating Lung-Cancer Cells
- (2008) Shyamala Maheswaran et al. NEW ENGLAND JOURNAL OF MEDICINE
- Circulating microRNAs as stable blood-based markers for cancer detection
- (2008) P. S. Mitchell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More